You May Also Like

SUPPLEMENTARY TABLE 1. Search strategy to identify recombinant zoster vaccine (RZV) reports of selected pre-specified outcomes in the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018
Cite
CITE Title : SUPPLEMENTARY TABLE 1. Search strategy to identify recombinant zoster vaccine (RZV) reports of selected pre-specified outcomes in the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018 Published Date : February 28, 2019 Source : MMWR. Morbidity and mortality weekly report ; v. 68, no. 4 URL : https://stacks.cdc.gov/view/cdc/61560
• File Format:
Copy Export
• RIS
[PDF - 265.31 KB]
February 28, 2019 | MMWR. Morbidity and mortality weekly report ; v. 68, no. 4
Description:
Supplements: Post-licensure safety surveillance of recombinant zoster vaccine (Shingrix) —Vaccine Adverse Event Reporting System (VAERS), United Sta...
File Type:
[PDF - 265.31 KB]
File Type:
[PDF - 265.31 KB]

VAERS : Vaccine Adverse Event Reporting System : a national program for monitoring vaccine safety
Cite
CITE Title : VAERS : Vaccine Adverse Event Reporting System : a national program for monitoring vaccine safety Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.);United States. Food and Drug Administration.; Published Date : 12/17/03 URL : https://stacks.cdc.gov/view/cdc/31647
• File Format:
Copy Export
• RIS
[PDF - 466.12 KB]
Corporate Authors:
Centers for Disease Control and Prevention (U.S.) ...
12/17/03
Description:
The Vaccine Adverse Event Reporting System (VAERS) is a national program that monitors the safety of vaccines after they are licensed. VAERS is manage...
File Type:
[PDF - 466.12 KB]
File Type:
[PDF - 466.12 KB]